 Jessica Kendrick
Concepts (275)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Renal Insufficiency, Chronic | 19 | 2025 | 612 | 4.760 |
Why?
| | Kidney Failure, Chronic | 13 | 2023 | 566 | 3.160 |
Why?
| | Renal Dialysis | 10 | 2023 | 435 | 2.710 |
Why?
| | Acidosis | 3 | 2025 | 101 | 2.100 |
Why?
| | Phosphorus | 6 | 2022 | 97 | 2.080 |
Why?
| | Kidney Diseases | 8 | 2023 | 407 | 1.850 |
Why?
| | Sodium Bicarbonate | 3 | 2025 | 45 | 1.720 |
Why?
| | Kidney Transplantation | 4 | 2022 | 701 | 1.640 |
Why?
| | Hyperparathyroidism, Secondary | 4 | 2025 | 12 | 1.640 |
Why?
| | Nephrology | 2 | 2024 | 61 | 1.480 |
Why?
| | Cardiovascular Diseases | 12 | 2023 | 2104 | 1.460 |
Why?
| | Bicarbonates | 3 | 2023 | 44 | 1.390 |
Why?
| | Ferric Compounds | 2 | 2022 | 56 | 1.340 |
Why?
| | Sucrose | 2 | 2022 | 110 | 1.330 |
Why?
| | Kidney | 11 | 2024 | 1467 | 1.300 |
Why?
| | Diet | 4 | 2023 | 1274 | 1.230 |
Why?
| | Cognition | 3 | 2025 | 1146 | 1.170 |
Why?
| | Pregnancy Complications | 3 | 2018 | 524 | 1.110 |
Why?
| | Vitamin D | 11 | 2018 | 397 | 1.070 |
Why?
| | Glomerular Filtration Rate | 9 | 2024 | 745 | 1.030 |
Why?
| | Blood Pressure | 5 | 2016 | 1774 | 0.950 |
Why?
| | Acute Kidney Injury | 3 | 2023 | 809 | 0.950 |
Why?
| | Potassium | 2 | 2014 | 147 | 0.860 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2024 | 128 | 0.830 |
Why?
| | Glomerulonephritis, IGA | 1 | 2023 | 11 | 0.820 |
Why?
| | Cerebrovascular Circulation | 1 | 2025 | 241 | 0.820 |
Why?
| | Cognitive Dysfunction | 2 | 2025 | 381 | 0.810 |
Why?
| | Fellowships and Scholarships | 2 | 2024 | 303 | 0.810 |
Why?
| | Hyperphosphatemia | 2 | 2022 | 15 | 0.810 |
Why?
| | Abortion, Legal | 1 | 2023 | 24 | 0.790 |
Why?
| | Vitamin D Deficiency | 5 | 2013 | 186 | 0.760 |
Why?
| | Healthcare Disparities | 3 | 2022 | 649 | 0.760 |
Why?
| | Complement Factor B | 1 | 2023 | 109 | 0.760 |
Why?
| | Calcimimetic Agents | 1 | 2021 | 3 | 0.750 |
Why?
| | Transition to Adult Care | 1 | 2023 | 81 | 0.740 |
Why?
| | Hypertension | 4 | 2016 | 1284 | 0.710 |
Why?
| | Peritoneal Dialysis | 1 | 2022 | 97 | 0.690 |
Why?
| | Humans | 61 | 2025 | 136768 | 0.690 |
Why?
| | Eating | 1 | 2023 | 379 | 0.690 |
Why?
| | Infant, Low Birth Weight | 2 | 2018 | 140 | 0.680 |
Why?
| | Infant Mortality | 2 | 2018 | 116 | 0.670 |
Why?
| | Phosphates | 3 | 2022 | 182 | 0.650 |
Why?
| | Nutritional Status | 3 | 2022 | 344 | 0.640 |
Why?
| | Pregnancy Outcome | 3 | 2018 | 412 | 0.620 |
Why?
| | Pre-Eclampsia | 2 | 2018 | 189 | 0.600 |
Why?
| | Nutrition Surveys | 5 | 2014 | 266 | 0.600 |
Why?
| | Vascular Calcification | 3 | 2018 | 108 | 0.590 |
Why?
| | Bone Diseases, Metabolic | 1 | 2018 | 62 | 0.560 |
Why?
| | Aged | 23 | 2025 | 23794 | 0.560 |
Why?
| | Calcium | 3 | 2021 | 1197 | 0.550 |
Why?
| | Antihypertensive Agents | 3 | 2016 | 487 | 0.540 |
Why?
| | Middle Aged | 26 | 2025 | 33228 | 0.530 |
Why?
| | Renal Insufficiency | 1 | 2019 | 155 | 0.520 |
Why?
| | Female | 35 | 2025 | 72796 | 0.510 |
Why?
| | Double-Blind Method | 7 | 2025 | 1981 | 0.510 |
Why?
| | Living Donors | 1 | 2018 | 295 | 0.510 |
Why?
| | Minerals | 2 | 2015 | 42 | 0.500 |
Why?
| | Male | 33 | 2025 | 67311 | 0.490 |
Why?
| | United States | 13 | 2025 | 14691 | 0.480 |
Why?
| | Parathyroid Hormone | 6 | 2021 | 108 | 0.470 |
Why?
| | Fibroblast Growth Factors | 4 | 2012 | 171 | 0.460 |
Why?
| | Prospective Studies | 8 | 2023 | 7572 | 0.450 |
Why?
| | Adult | 20 | 2024 | 37630 | 0.450 |
Why?
| | Endothelium, Vascular | 2 | 2018 | 926 | 0.440 |
Why?
| | Risk Factors | 12 | 2020 | 10326 | 0.440 |
Why?
| | Diabetic Nephropathies | 3 | 2022 | 294 | 0.430 |
Why?
| | Sodium Chloride, Dietary | 1 | 2014 | 36 | 0.430 |
Why?
| | Sodium | 1 | 2014 | 216 | 0.420 |
Why?
| | Potassium, Dietary | 1 | 2013 | 12 | 0.410 |
Why?
| | Atherosclerosis | 2 | 2016 | 415 | 0.410 |
Why?
| | Sodium, Dietary | 1 | 2013 | 41 | 0.400 |
Why?
| | Heart Arrest | 1 | 2016 | 338 | 0.400 |
Why?
| | Pilot Projects | 3 | 2025 | 1692 | 0.400 |
Why?
| | Kidney Function Tests | 2 | 2010 | 159 | 0.390 |
Why?
| | Perception | 1 | 2015 | 359 | 0.380 |
Why?
| | Myocardial Infarction | 2 | 2016 | 1041 | 0.360 |
Why?
| | Disease Management | 1 | 2015 | 624 | 0.350 |
Why?
| | Clinical Trials as Topic | 2 | 2022 | 1044 | 0.340 |
Why?
| | Ankle Brachial Index | 1 | 2010 | 37 | 0.340 |
Why?
| | Patient Selection | 1 | 2014 | 690 | 0.330 |
Why?
| | Pregnancy | 5 | 2024 | 6728 | 0.330 |
Why?
| | Socioeconomic Factors | 1 | 2015 | 1282 | 0.330 |
Why?
| | Internship and Residency | 1 | 2020 | 1132 | 0.330 |
Why?
| | Follow-Up Studies | 6 | 2018 | 5106 | 0.330 |
Why?
| | Health Services Accessibility | 1 | 2017 | 978 | 0.330 |
Why?
| | Stroke | 2 | 2016 | 1118 | 0.320 |
Why?
| | Lovastatin | 1 | 2009 | 37 | 0.320 |
Why?
| | Drug Combinations | 2 | 2022 | 343 | 0.320 |
Why?
| | Patient Education as Topic | 1 | 2014 | 761 | 0.310 |
Why?
| | Health Status | 1 | 2014 | 788 | 0.300 |
Why?
| | Renal Artery Obstruction | 1 | 2008 | 30 | 0.300 |
Why?
| | Cohort Studies | 6 | 2019 | 5701 | 0.280 |
Why?
| | Primary Prevention | 1 | 2009 | 196 | 0.280 |
Why?
| | Colitis, Ischemic | 1 | 2007 | 6 | 0.280 |
Why?
| | Enterocolitis, Pseudomembranous | 1 | 2007 | 29 | 0.270 |
Why?
| | Escherichia coli O157 | 1 | 2007 | 31 | 0.270 |
Why?
| | Proportional Hazards Models | 3 | 2016 | 1261 | 0.270 |
Why?
| | Incidence | 4 | 2018 | 2792 | 0.260 |
Why?
| | Attitude of Health Personnel | 1 | 2015 | 1163 | 0.260 |
Why?
| | Escherichia coli Infections | 1 | 2007 | 111 | 0.260 |
Why?
| | Hemoglobins | 1 | 2009 | 353 | 0.260 |
Why?
| | Health Surveys | 1 | 2008 | 513 | 0.260 |
Why?
| | Aged, 80 and over | 6 | 2025 | 7585 | 0.250 |
Why?
| | Comorbidity | 3 | 2020 | 1614 | 0.250 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2015 | 1320 | 0.250 |
Why?
| | Critical Illness | 2 | 2023 | 804 | 0.250 |
Why?
| | Surveys and Questionnaires | 4 | 2025 | 5742 | 0.250 |
Why?
| | Insulin Resistance | 3 | 2024 | 1203 | 0.240 |
Why?
| | Ultrasonography, Doppler, Transcranial | 1 | 2025 | 45 | 0.240 |
Why?
| | Middle Cerebral Artery | 1 | 2025 | 53 | 0.240 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2024 | 2518 | 0.220 |
Why?
| | Primary Health Care | 1 | 2015 | 1721 | 0.220 |
Why?
| | Pulse Wave Analysis | 2 | 2023 | 269 | 0.210 |
Why?
| | Treatment Outcome | 7 | 2019 | 10744 | 0.210 |
Why?
| | Heart Failure | 1 | 2016 | 2231 | 0.200 |
Why?
| | Coronary Artery Disease | 1 | 2009 | 698 | 0.200 |
Why?
| | Albuminuria | 3 | 2020 | 185 | 0.200 |
Why?
| | Hyperoxia | 1 | 2024 | 90 | 0.200 |
Why?
| | Plant Proteins | 1 | 2023 | 113 | 0.200 |
Why?
| | Proteinuria | 1 | 2023 | 97 | 0.200 |
Why?
| | Communication | 2 | 2022 | 875 | 0.200 |
Why?
| | Military Personnel | 1 | 2009 | 544 | 0.200 |
Why?
| | Kidney Glomerulus | 1 | 2023 | 114 | 0.200 |
Why?
| | Hypoalbuminemia | 1 | 2022 | 30 | 0.190 |
Why?
| | Meals | 1 | 2023 | 125 | 0.190 |
Why?
| | Serum Albumin | 1 | 2022 | 150 | 0.180 |
Why?
| | Disease Progression | 4 | 2015 | 2750 | 0.180 |
Why?
| | Prevalence | 4 | 2017 | 2711 | 0.180 |
Why?
| | Infant, Newborn | 3 | 2018 | 6033 | 0.180 |
Why?
| | Inflammation | 2 | 2009 | 2835 | 0.170 |
Why?
| | Calcinosis | 2 | 2014 | 235 | 0.170 |
Why?
| | Fruit | 1 | 2021 | 139 | 0.170 |
Why?
| | Young Adult | 5 | 2024 | 13129 | 0.160 |
Why?
| | Time Factors | 3 | 2019 | 6808 | 0.160 |
Why?
| | Educational Status | 1 | 2022 | 470 | 0.160 |
Why?
| | Education, Medical, Graduate | 1 | 2024 | 481 | 0.160 |
Why?
| | Neuropsychological Tests | 1 | 2024 | 1022 | 0.160 |
Why?
| | Complement System Proteins | 1 | 2022 | 327 | 0.160 |
Why?
| | Creatinine | 2 | 2020 | 499 | 0.150 |
Why?
| | Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 2018 | 14 | 0.150 |
Why?
| | Receptors, Calcium-Sensing | 1 | 2018 | 6 | 0.150 |
Why?
| | Vitamin D-Binding Protein | 1 | 2018 | 15 | 0.150 |
Why?
| | Chelating Agents | 1 | 2019 | 75 | 0.150 |
Why?
| | Career Choice | 1 | 2020 | 216 | 0.140 |
Why?
| | Carotid Intima-Media Thickness | 1 | 2018 | 90 | 0.140 |
Why?
| | Intestinal Absorption | 1 | 2018 | 102 | 0.140 |
Why?
| | Biomarkers | 3 | 2023 | 4144 | 0.140 |
Why?
| | Focus Groups | 1 | 2020 | 515 | 0.140 |
Why?
| | Uric Acid | 1 | 2018 | 163 | 0.140 |
Why?
| | Retrospective Studies | 5 | 2021 | 15504 | 0.130 |
Why?
| | Case-Control Studies | 4 | 2018 | 3540 | 0.130 |
Why?
| | Metformin | 1 | 2020 | 330 | 0.130 |
Why?
| | Diuretics | 1 | 2016 | 74 | 0.130 |
Why?
| | Congenital Abnormalities | 1 | 2017 | 88 | 0.130 |
Why?
| | Adolescent | 6 | 2024 | 21382 | 0.130 |
Why?
| | Odds Ratio | 3 | 2014 | 1065 | 0.130 |
Why?
| | Cross-Over Studies | 1 | 2018 | 562 | 0.120 |
Why?
| | Practice Patterns, Physicians' | 1 | 2025 | 1301 | 0.120 |
Why?
| | Prognosis | 2 | 2018 | 4013 | 0.120 |
Why?
| | Peptides | 1 | 2021 | 980 | 0.120 |
Why?
| | Physician-Patient Relations | 1 | 2020 | 548 | 0.120 |
Why?
| | Waiting Lists | 1 | 2017 | 262 | 0.120 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2015 | 92 | 0.120 |
Why?
| | Polymorphism, Genetic | 1 | 2018 | 659 | 0.120 |
Why?
| | Obstetric Labor, Premature | 1 | 2015 | 36 | 0.110 |
Why?
| | Medication Adherence | 1 | 2019 | 466 | 0.110 |
Why?
| | Maternal Mortality | 1 | 2015 | 45 | 0.110 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2015 | 201 | 0.110 |
Why?
| | Transcription Factor CHOP | 1 | 2014 | 31 | 0.110 |
Why?
| | Ethics Committees, Research | 1 | 2014 | 41 | 0.110 |
Why?
| | Infant, Small for Gestational Age | 1 | 2015 | 91 | 0.110 |
Why?
| | Cultural Competency | 1 | 2015 | 83 | 0.110 |
Why?
| | Precision Medicine | 1 | 2018 | 426 | 0.110 |
Why?
| | Awareness | 1 | 2015 | 102 | 0.110 |
Why?
| | Risk Assessment | 2 | 2017 | 3432 | 0.110 |
Why?
| | Professional-Patient Relations | 1 | 2015 | 143 | 0.110 |
Why?
| | Cesarean Section | 1 | 2015 | 183 | 0.100 |
Why?
| | Premature Birth | 1 | 2017 | 331 | 0.100 |
Why?
| | Pneumonia, Bacterial | 1 | 2014 | 116 | 0.100 |
Why?
| | Simvastatin | 2 | 2014 | 61 | 0.100 |
Why?
| | Health Care Surveys | 1 | 2015 | 562 | 0.100 |
Why?
| | Infant | 2 | 2018 | 9398 | 0.100 |
Why?
| | Cause of Death | 1 | 2015 | 430 | 0.100 |
Why?
| | Global Health | 1 | 2015 | 385 | 0.090 |
Why?
| | Community-Acquired Infections | 1 | 2014 | 169 | 0.090 |
Why?
| | Logistic Models | 3 | 2014 | 2067 | 0.090 |
Why?
| | Endoplasmic Reticulum | 1 | 2014 | 264 | 0.090 |
Why?
| | Academic Medical Centers | 1 | 2015 | 504 | 0.090 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2015 | 253 | 0.090 |
Why?
| | Cross-Sectional Studies | 3 | 2013 | 5423 | 0.090 |
Why?
| | Vascular Diseases | 1 | 2014 | 243 | 0.090 |
Why?
| | Cooperative Behavior | 1 | 2014 | 445 | 0.090 |
Why?
| | Chronic Disease | 4 | 2012 | 1785 | 0.090 |
Why?
| | Research | 1 | 2014 | 448 | 0.090 |
Why?
| | Metabolic Diseases | 1 | 2012 | 108 | 0.090 |
Why?
| | Survival Rate | 1 | 2015 | 1963 | 0.090 |
Why?
| | Infant, Premature | 1 | 2015 | 566 | 0.080 |
Why?
| | Fatty Liver | 1 | 2013 | 243 | 0.080 |
Why?
| | Tunica Media | 1 | 2010 | 38 | 0.080 |
Why?
| | Tunica Intima | 1 | 2010 | 84 | 0.080 |
Why?
| | Systole | 1 | 2010 | 189 | 0.080 |
Why?
| | Length of Stay | 1 | 2015 | 1205 | 0.080 |
Why?
| | Bone and Bones | 1 | 2012 | 316 | 0.080 |
Why?
| | Texas | 1 | 2009 | 243 | 0.080 |
Why?
| | Radioisotope Renography | 1 | 2008 | 4 | 0.080 |
Why?
| | Metabolic Syndrome | 1 | 2012 | 354 | 0.080 |
Why?
| | Calcium, Dietary | 1 | 2009 | 57 | 0.080 |
Why?
| | Complement Activation | 2 | 2022 | 410 | 0.070 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 2008 | 39 | 0.070 |
Why?
| | Tomography, Spiral Computed | 1 | 2008 | 32 | 0.070 |
Why?
| | Cholecalciferol | 1 | 2009 | 60 | 0.070 |
Why?
| | Child | 3 | 2023 | 21822 | 0.070 |
Why?
| | Cardiovascular System | 1 | 2010 | 137 | 0.070 |
Why?
| | Causality | 1 | 2008 | 126 | 0.070 |
Why?
| | Sepsis | 1 | 2014 | 614 | 0.070 |
Why?
| | Age Distribution | 1 | 2008 | 389 | 0.070 |
Why?
| | Sex Distribution | 1 | 2008 | 373 | 0.070 |
Why?
| | Vitamins | 1 | 2009 | 185 | 0.070 |
Why?
| | Homeostasis | 1 | 2011 | 619 | 0.070 |
Why?
| | Anemia | 1 | 2008 | 170 | 0.070 |
Why?
| | Biopsy, Needle | 1 | 2007 | 189 | 0.070 |
Why?
| | Anastomosis, Surgical | 1 | 2007 | 152 | 0.070 |
Why?
| | Colectomy | 1 | 2007 | 100 | 0.060 |
Why?
| | Rare Diseases | 1 | 2007 | 101 | 0.060 |
Why?
| | C-Reactive Protein | 1 | 2009 | 408 | 0.060 |
Why?
| | Magnetic Resonance Angiography | 1 | 2008 | 240 | 0.060 |
Why?
| | Oxidative Stress | 2 | 2014 | 1314 | 0.060 |
Why?
| | Coronary Disease | 1 | 2008 | 384 | 0.060 |
Why?
| | Abdominal Pain | 1 | 2007 | 145 | 0.060 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2011 | 1462 | 0.060 |
Why?
| | Ischemia | 1 | 2008 | 407 | 0.060 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2009 | 443 | 0.060 |
Why?
| | Survival Analysis | 1 | 2008 | 1321 | 0.060 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2009 | 2052 | 0.060 |
Why?
| | Colonoscopy | 1 | 2007 | 245 | 0.060 |
Why?
| | Colorado | 1 | 2015 | 4518 | 0.060 |
Why?
| | Dietary Supplements | 1 | 2009 | 559 | 0.060 |
Why?
| | Longitudinal Studies | 1 | 2011 | 2829 | 0.050 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2020 | 3710 | 0.050 |
Why?
| | Delphi Technique | 1 | 2025 | 273 | 0.050 |
Why?
| | Immunohistochemistry | 1 | 2007 | 1733 | 0.050 |
Why?
| | Severity of Illness Index | 2 | 2009 | 2822 | 0.050 |
Why?
| | Atypical Hemolytic Uremic Syndrome | 1 | 2022 | 22 | 0.050 |
Why?
| | Drug Therapy, Combination | 2 | 2015 | 1062 | 0.050 |
Why?
| | Intestinal Mucosa | 1 | 2007 | 621 | 0.050 |
Why?
| | Consensus | 1 | 2025 | 678 | 0.050 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2022 | 133 | 0.040 |
Why?
| | Oxygen | 1 | 2024 | 930 | 0.040 |
Why?
| | Allopurinol | 1 | 2018 | 63 | 0.040 |
Why?
| | Intensive Care Units | 1 | 2021 | 800 | 0.030 |
Why?
| | Ketocholesterols | 1 | 2014 | 7 | 0.030 |
Why?
| | Ezetimibe | 1 | 2014 | 24 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2014 | 61 | 0.030 |
Why?
| | Azetidines | 1 | 2014 | 43 | 0.030 |
Why?
| | Apolipoproteins E | 1 | 2014 | 83 | 0.030 |
Why?
| | Phenotype | 1 | 2022 | 3189 | 0.030 |
Why?
| | Human Umbilical Vein Endothelial Cells | 1 | 2014 | 106 | 0.030 |
Why?
| | Insulin | 1 | 2024 | 2406 | 0.030 |
Why?
| | Hypoglycemic Agents | 1 | 2022 | 1283 | 0.020 |
Why?
| | Brachial Artery | 1 | 2014 | 201 | 0.020 |
Why?
| | Aorta | 1 | 2014 | 417 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2012 | 530 | 0.020 |
Why?
| | Risk | 1 | 2012 | 908 | 0.020 |
Why?
| | Lipids | 1 | 2014 | 665 | 0.020 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2013 | 279 | 0.020 |
Why?
| | Linear Models | 1 | 2012 | 846 | 0.020 |
Why?
| | Scandinavian and Nordic Countries | 1 | 2008 | 13 | 0.020 |
Why?
| | Ultrasonography | 1 | 2013 | 752 | 0.020 |
Why?
| | Placebos | 1 | 2008 | 199 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2012 | 1507 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2014 | 3008 | 0.020 |
Why?
| | Immunity, Innate | 1 | 2011 | 825 | 0.010 |
Why?
| | Body Mass Index | 1 | 2013 | 2375 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2014 | 5749 | 0.010 |
Why?
| | Animals | 1 | 2014 | 36847 | 0.010 |
Why?
|
|
Kendrick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|